- Report
- November 2025
- 354 Pages
Global
From €5256EUR$5,850USD£4,637GBP
- Report
- November 2025
- 291 Pages
Global
From €5256EUR$5,850USD£4,637GBP
- Report
- November 2025
- 283 Pages
Global
From €5256EUR$5,850USD£4,637GBP
- Report
- November 2025
- 268 Pages
Global
From €5256EUR$5,850USD£4,637GBP
- Report
- November 2025
- 259 Pages
Global
From €5256EUR$5,850USD£4,637GBP
- Report
- November 2025
- 482 Pages
Global
From €5256EUR$5,850USD£4,637GBP
- Report
- November 2025
- 272 Pages
Global
From €5256EUR$5,850USD£4,637GBP
- Report
- November 2025
- 196 Pages
Global
From €5256EUR$5,850USD£4,637GBP
- Report
- November 2025
- 340 Pages
Global
From €5256EUR$5,850USD£4,637GBP
- Report
- November 2025
- 177 Pages
Global
From €5256EUR$5,850USD£4,637GBP
- Report
- November 2025
- 168 Pages
Global
From €5256EUR$5,850USD£4,637GBP
- Report
- November 2025
- 190 Pages
Global
From €5256EUR$5,850USD£4,637GBP
- Report
- November 2025
- 180 Pages
Global
From €5256EUR$5,850USD£4,637GBP
- Report
- November 2025
- 130 Pages
Global
From €5256EUR$5,850USD£4,637GBP
- Report
- November 2025
- 349 Pages
Global
From €5256EUR$5,850USD£4,637GBP
- Report
- November 2025
- 179 Pages
Global
From €5256EUR$5,850USD£4,637GBP
- Report
- November 2025
- 189 Pages
Global
From €5256EUR$5,850USD£4,637GBP
- Report
- November 2025
- 413 Pages
Global
From €5256EUR$5,850USD£4,637GBP
- Report
- November 2025
- 264 Pages
Global
From €5256EUR$5,850USD£4,637GBP
- Report
- November 2025
- 322 Pages
Global
From €5256EUR$5,850USD£4,637GBP

The Drugs by Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs for specific medical conditions. These drugs are designed to treat a wide range of diseases, from cancer to mental health disorders. Companies in this market typically specialize in one or more therapeutic areas, such as oncology, neurology, or cardiology. They develop drugs that target specific medical conditions and then market them to healthcare providers and patients. Companies in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, and Sanofi. Show Less Read more